Resources

Please find the session links next to their corresponding agenda item.

Thursday, December 2

FDLI Welcome and Opening Presentation
April Inyard Alexandrow, Science and Policy Coordinator, FDA Cannabis Product Committee, Office of the Commissioner, FDA
Amy Comstock Rick
, President & CEO, FDLI

Watch this session: https://fdli.vids.io/videos/709dd7bb1a12eec5f9/fdli-cannabis-conference-day-1-session-1-welcome-and-keynote

 

 

Present and Future Federal Marijuana Policies and Interplay with State Regulatory Frameworks
Mark Bolton
, Head of Global Public Policy, Jazz Pharmaceuticals, Inc.
Andrew Freedman
, Senior Vice President, Forbes Tate Partners
Andrew J. Kline
, Senior Counsel, Perkins Coie LLP
Moderated by William Garvin, Shareholder, Buchanan Ingersoll & Rooney PC

Enter this session: https://fdli.vids.io/videos/119dd7bb1b1ee6cd98/fdli-cannabis-conference-day-1-session-2-present-and-future-federal-marijuana-policies-and-interplay-with-state-regulatory-frameworks

 

How States are Responding to Marijuana’s Public Health Concerns and Implications for Possible Federal Regulation
James T. O’Reilly, Volunteer Professor, University of Cincinnati School of Medicine
Gillian L. Schauer, Executive Director, Cannabis Regulators Association
George Sam Wang, Associate Professor of Pediatrics, Section of Emergency Medicine and Medical Toxicology, Department of Pediatrics, University of Colorado Anschutz Medical Campus, Children’s Hospital Colorado
Moderated by Deborah Miran, Consultant, DMiran Consulting

Enter this session: https://fdli.zoom.us/j/86771429860

 

State and Federal Marijuana Policies: Addressing Racial Bias and Social Equity Reform
John Hudak, Deputy Director, Center for Effective Public Management, The Brookings Institution
Danielle K. Perry, Cannabis Regulation Oversight Officer, State of Illinois
Shawn “Pepper” Roussel, Attorney at Law, Green Pepper Solutions
Alyssa Samuel, Attorney, Husch Blackwell LLP

Enter this session: https://fdli.vids.io/videos/449dd7bb1b12e3c5cd/fdli-cannabis-conference-day-1-session-4-state-and-federal-marijuana-policies-addressing-racial-bias-and-social-equity-reform

 

International Cannabis Regulation: Impact and Considerations for a U.S. Framework
Eileen McMahon, Partner, Torys LLP
Joseph Wyse, Head of Patent Department, Dr. Eyal Bressler & Co. Ltd.
Moderated by Jessica Wasserman, Partner, WassermanRowe LLC and Chair, Science and Regulatory Affairs Committee, Council for Federal Cannabis Regulation (CFCR)

Enter this session: https://fdli.vids.io/videos/a79dd7bb1415e3c22e/fdli-cannabis-conference-day-1-session-5-international-cannabis-regulation-impact-and-considerations-for-a-u-s-framework

 

The Hazy Legal Status of Synthetic Cannabinoids
Edgar J. Asebey, Partner, Keller Asebey Life Science Law PLLC
Brad Douglass, Independent Consultant, EAS Consulting Group
Howard R. Sklamberg, Partner, Arnold & Porter LLP
Moderated by Thomas Tobin, Associate, Perkins Coie LLP

Enter this session: https://fdli.vids.io/videos/a79dd7bb1416e5c72e/fdli-cannabis-conference-day-1-session-6-the-hazy-legal-status-of-synthetic-cannabinoids

 

Friday, December 3

Achieving High Product Quality and Good Manufacturing Practices for Cannabis Products
Tara Lin Couch, Senior Director of Dietary Supplement and Tobacco Services, EAS Consulting Group
Steven M. Gendel, Independent Consultant
David Vaillencourt, CEO & Founder, The GMP Collective and Vice Chair, ASTM International Committee D37 on Cannabis
Moderated by Delia Ann Deschaine, Member of the Firm, Epstein Becker & Green, PC

Enter this session: https://fdli.vids.io/videos/799dd7b4131ce5c3f0/fdli-cannabis-conference-day-2-session-1-welcome-and-achieving-high-product-quality-and-good-manufacturing-practices-for-cannabis-products

 

FDA’s Search for Data to Inform Cannabidiol Regulation as a Food and Dietary Ingredient
Robert Durkin, Of Counsel, Arnall Golden Gregory LLP
Jonathan A. Havens, Partner, Saul Ewing Arnstein & Lehr LLP
Brian J. Malkin, Partner, McDermott Will & Emery LLP
Elizabeth Oestreich, VP Regulatory Compliance, Greenleaf Health, Inc.

Enter this session: https://fdli.vids.io/videos/449dd7b4131ee6cbcd/fdli-cannabis-conference-day-2-session-2-fdas-search-for-data-to-inform-cannabidiol-regulation-as-a-food-and-dietary-ingredient

 

 

Legal, Regulatory, and Economic Challenges Facing Cannabis Growers
Stan Benda, Barrister & Solicitor / Adjunct Professor, Osgoode Hall Law School, York University
Elizabeth Kruman, Acting Deputy Assistant General Counsel, Marketing, Regulatory, and Food Safety Programs Division, USDA
Keith Matthews, Of Counsel, Wiley LLP
Moderated by Frederick R. Ball, Partner, Duane Morris LLP and Treasurer, FDLI Board of Directors

Enter this session: https://fdli.vids.io/videos/069dd7b41319e5c58f/fdli-cannabis-conference-day-2-session-3-legal-regulatory-and-economic-challenges-facing-cannabis-growers

 

Will Increased Supply Options Affect Marijuana Research and Drug Development?
Jacci Bainbridge, Professor, Skaggs School of Pharmacy and Pharmaceutical Sciences, Department of Clinical Pharmacy, University of Colorado and Department of Neurology Anschutz Medical Campus
Rodney Butt, Senior Vice President – Strategic Solutions, Nutrasource Pharmaceutical and Nutraceutical Services
Heike Newman, Senior Regulatory Manager, University of Colorado
Moderated by Kate W. Hardey, Partner, McGuireWoods LLP

Enter this session: https://fdli.vids.io/videos/ac9dd7b4131be6c625/fdli-cannabis-conference-day-2-session-4-will-increased-supply-options-affect-marijuana-research-and-drug-development

 

 

Virtual Learning FAQ

On-demand webinar content is sent via email as soon as we are able to process and verify your order. This usually occurs within 1 business day.

 

On-demand content can be played back on most devices.

 

CLE credit is not currently available for pre-recorded sessions.